Innovation Pharmaceuticals Inc. (IPIX)

OTCMKTS · Delayed Price · Currency is USD
0.0007
0.00 (0.00%)
Mar 4, 2026, 9:30 AM EST
600.00%
Market Cap 370.14K
Revenue (ttm) n/a
Net Income (ttm) -2.62M
Shares Out 528.77M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 10,700
Average Volume 176,449
Open 0.0007
Previous Close 0.0007
Day's Range 0.0002 - 0.0007
52-Week Range n/a
Beta 158.38
RSI 50.52
Earnings Date n/a

About IPIX

Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Its lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19. The company has a license agreement with Alfasigma S.p.A.; and collaborative research agreement with Fox Chase Chemical Diversity Center, Inc. The company was formerly known as Cellc... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2005
Employees 4
Stock Exchange OTCMKTS
Ticker Symbol IPIX
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.